Encompass Health/$EHC
1D1W1MYTD1Y5YMAX
About Encompass Health
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
- Ticker
- $EHC
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 29,699
- Headquarters
- Birmingham, United States
- Website
- www.encompasshealth.com
Encompass Health Metrics
BasicAdvanced
$12B
19.97
$6.14
0.60
$0.76
0.62%
Price and volume
Market cap
$12B
Beta
0.6
52-week high
$127.99
52-week low
$92.77
Average daily volume
916K
Dividend rate
$0.76
Financial strength
Current ratio
1.192
Quick ratio
0.91
Long term debt to equity
80.29
Total debt to equity
82.121
Dividend payout ratio (TTM)
12.11%
Interest coverage (TTM)
8.89%
Profitability
EBITDA (TTM)
1,463.5
Gross margin (TTM)
43.86%
Net profit margin (TTM)
10.01%
Operating margin (TTM)
18.00%
Effective tax rate (TTM)
20.46%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
9.80%
Return on equity (TTM)
24.97%
Valuation
Price to earnings (TTM)
19.969
Price to revenue (TTM)
1.969
Price to book
4.66
Price to tangible book (TTM)
12.52
Price to free cash flow (TTM)
29.565
Free cash flow yield (TTM)
3.38%
Free cash flow per share (TTM)
4.146
Dividend yield (TTM)
0.62%
Forward dividend yield
0.62%
Growth
Revenue change (TTM)
9.47%
Earnings per share change (TTM)
20.15%
3-year revenue growth (CAGR)
10.70%
10-year revenue growth (CAGR)
6.10%
3-year earnings per share growth (CAGR)
25.36%
10-year earnings per share growth (CAGR)
10.41%
3-year dividend per share growth (CAGR)
8.20%
10-year dividend per share growth (CAGR)
-1.89%
What the Analysts think about Encompass Health
Analyst ratings (Buy, Hold, Sell) for Encompass Health stock.
Encompass Health Financial Performance
Revenues and expenses
Encompass Health Earnings Performance
Company profitability
Encompass Health News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.